I guess what surprises me is how low I think the bar is set on what constitutes a drug being fit for market release. In my world I would expect any new drug to be absolutely clearly and substantially better, more effective and safer than an existing one on the market, but that doesn't really seem to be the case in practice. I was also genuinely surprised to learn that companies can add a bit of sugar coating or caffeine into the coating of a tablet and then sell it at 10 x the price of a tablet that is exactly the same drug and exactly the same dosage. I just don't see how marketing should have any place in Healthcare at all.I would not neccessarily say I trust 'global conglomerates', but I do have a lot of trust for the regulatory bodies (MHRA, EMA, FDA, PDMA) to scrutinise and regulate them. I'm just saying how I see it.
As an aside, yesterday you said 'I also work closely with Big Pharma in my job, and I am regularly surprised at some of the stuff that goes on in clinical trials.' - what have you heard? I am curious.
I was surprised to learn that drug companies have been regularly fined billions of dollars for bribing doctors to prescribe their drugs, and nobody seems to care. But most of all I am regularly surprised at some of the utter incompetence of the people working on clinical trials, and how often I hear of people being told to do unethical and even illegal things to help CRO's win / not lose clinical studies. I've heard it so many times.
I guess it's complete naivety on my part, but before I went into this game I just kind of assumed that Healthcare was an area that was trustworthy and not to be questioned. Which is a pretty ridiculous viewpoint on a market that makes billions of dollars from it's customers being, and staying unhealthy.